Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [21] Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification
    Neal D. Shore
    Judd W. Moul
    Kenneth J. Pienta
    Johannes Czernin
    Martin T. King
    Stephen J. Freedland
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 192 - 201
  • [22] Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification
    Shore, Neal D.
    Moul, Judd W.
    Pienta, Kenneth J.
    Czernin, Johannes
    King, Martin T.
    Freedland, Stephen J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 192 - 201
  • [23] Statin use and risk of breast cancer: a meta-analysis of observational studies
    Krishna Undela
    Vallakatla Srikanth
    Dipika Bansal
    Breast Cancer Research and Treatment, 2012, 135 : 261 - 269
  • [24] PHOSPHODIESTERASE TYPE 5 INHIBITOR USE IS NOT ASSOCIATED WITH BIOCHEMICAL RECURRENCE AFTER DEFINITIVE THERAPY FOR PROSTATE CANCER
    Leapman, Michael
    Nguyen, Hao
    Cowan, Janet
    Porten, Sima
    Meng, Maxwell
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1043 - E1043
  • [25] Statin use and risk of breast cancer: a meta-analysis of observational studies
    Undela, Krishna
    Srikanth, Vallakatla
    Bansal, Dipika
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (01) : 261 - 269
  • [26] Prime-boost immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer
    Stein, Mark N.
    Hawley, Jessica E.
    Pachynski, Russell Kent
    Zarrabi, Kevin Kayvan
    Dreicer, Robert
    Zibelman, Matthew R.
    Marshall, Margaret A.
    Jones, Bethan
    Wheeler, Vicky
    Sebastian, Sarah
    Bendall, Jennifer
    Anderson, Katie
    Shore, Neal D.
    Graff, Julie N.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Statin Use Is Associated with Better Prognosis of Patients with Prostate Cancer after Definite Therapies: A Systematic Review and Meta-Analysis of Cohort Studies
    An, Ye
    Sun, Jian-Xuan
    Xu, Meng-Yao
    Liu, Chen-Qian
    Xu, Jin-Zhou
    Zhong, Xing-Yu
    Hu, Jia
    Xia, Qi-Dong
    Hu, Heng-Long
    Wang, Shao-Gang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [28] Coffee Consumption and Prostate Cancer Risk: A Meta-Analysis of Cohort Studies
    Liu, Huan
    Hu, Guang-Hui
    Wang, Xing-Chun
    Huang, Tian-Bao
    Xu, Liang
    Lai, Peng
    Guo, Zhui-Feng
    Xu, Yun-Fei
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2015, 67 (03): : 392 - 400
  • [29] Periodontal disease and the risk of prostate cancer: a meta-analysis of cohort studies
    Guo, Zhenlang
    Gu, Chiming
    Li, Siyi
    Gan, Shu
    Li, Yuan
    Xiang, Songtao
    Gong, Leiliang
    Wang, Shusheng
    INTERNATIONAL BRAZ J UROL, 2021, 47 (06): : 1120 - 1130
  • [30] Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy
    Moul, JW
    MOLECULAR UROLOGY, 2000, 4 (03) : 267 - 271